二尖瓣成形术治疗二尖瓣关闭不全的疗效分析

目的分析二尖瓣瓣膜成形术(MVP)治疗中重度二尖瓣关闭不全(MR)患者的临床疗效。 方法以2013年6月至2017年6月徐州医科大学附属沭阳医院心胸外科收治的28例行MVP的MR患者为研究对象行回顾性分析,其中男性17例,女性11例;年龄50～72岁,平均(61.5±10.6)岁。所有患者术前均存在中重度MR。术前根据患者的合并症、病变部位的定位和合并腱索断裂与否,评估选择可行的MVP术式及合并手术：所有患者均采用正中切口、体外循环下手术治疗,术中行二尖瓣楔形切除、矩形切除及缘对缘缝合方法修补二尖瓣,合并腱索断裂或腱索冗长的行e-PTFE线人工腱索植入,常规行二尖瓣成型环植入,术中注水观察评估瓣膜成行效果。术中采取的二尖瓣成形方法统计：7例(25.0%)植入1～3根腱索,行二尖瓣矩切除术9例(32.1%),二尖瓣楔形切除术8例(28.6%),二尖瓣缘对缘缝合4例(14.3%),所有患者均置入鞍形二尖瓣成形环。对于合并心房颤动的患者同期行单纯左心耳切除术(LAA),或心房颤动射频消融术(AB)＋LAA;合并冠心病,则同期行冠状动脉搭桥术(CABG);合并中度及以上的三尖瓣关闭不全,则同期行三尖瓣成形环植入手术(TVP)。1例(3.6%)患者行MVP＋CABG,1例(3.6%)行MVP＋TVP＋LAA;3例(10.7%)行MVP＋TVP＋AB＋LAA;5例(17.9%)行MVP＋TVP;18例(64.3%)行单纯MVP。术后予华法林抗凝治疗3～6个月,合并心房颤动者终身抗凝治疗。统计所有患者采取的手术方式,包括合并手术、二尖瓣成形方法;对比患者术前及术后2年的返流、心功能改善情况以及LAD、左心室舒张末内径(LVEDD)、左心室射血分数(LVEF)水平的差异。 结果所有患者术前均为中重度返流,术后2年复查心脏彩超：21例(75.0%)无明显二尖瓣返流,6例(21.4%)二尖瓣轻度返流,1例(3.6%)二尖瓣中度返流。且所有患者的心功能较术前均提升1 ～ 2级。术前LAD[(49.42±12.58)mm],术后2年LAD[(38.17±9.84)mm],术前LVEDD[(50.91±7.93)mm],术后LVEDD[(44.37±7.42)mm],术后均较术前明显缩小;术前LVEF(51.69±9.71)%,术后LVEF(62.79±8.53)%,术后LVEF较术前明显增加。 结论MVP治疗MR安全有效、疗效显著,但远期效果还待进一步研究随访。     

Relevant factors in mitral valve reconstructive surgery. Report of 150 cases

150 patients had mitral valve repair for mitral valve incompetence. There were 57 males and 93 females with a mean age of 22 years, 39% were less than 15 years of age. 60% of the patients were in Class II NYHA and 40% in Class III and IV. According to Carpentier's classification, isolated type I was present in 18 patients (12%), type II in 98 patients (64%) and type III in 34 cases (24%). Mitral repair included correction of valve prolapse, valvular enlargement with pericardial patch and annuloplasty with semi-rigid ring in 128 cases and PTFE patch along the posterior leaflet in 12 cases. The perioperative mortality rate was 2.6% (4 patients). All patients had early post-operative echocardiography. According to this, mitral regurgitation was absent or tiny in 135 patients (92%), grade II in 10 cases and grade III in 2 cases. It was moderate or important in twelve patients (8%). In the late post-operative period, three patients were lost to follow-up. All the others patients were reoperated upon for mitral dysfunction in a mean time of 37 months. The reason for reoperation was in the majority of the cases the recurrence of mitral regurgitation related to increase of valvular and sub valvular disease. The late mortality rate is 7% (10 patients). Out of 126 reviewed survivors on the long run, 71 patients (56%) are asymptomatic in class I, 53 patients (42%) in class II and 2 patients in class III NYHA. Mitral valvuloplasty is the preferred procedure in mitral insufficiency surgical management. It is associated to a low early mortality and morbidity rate. Despite the need for reoperation in about 10% of the cases in the long follow-up, mitral repair offers a good quality of life without anticoagulant treatment.     

Determining factors in mitral valve reconstructive surgery. Report of 150 cases

150 patients had mitral valve repair for mitral valve incompetence. There were 57 males and 93 females with a mean age of 22 years. 60% of the patients were in Class II NYHA and 40% in Class III and IV. Type I was present in 18 patients, type II in 98 and type III in 34 cases. Mitral repair included correction of valve prolapse, valvular enlargement with pericardial patch and annuloplasty with semi-rigid ring in 128 cases and PTFE patch along the posterior leaflet in 12 cases. The perioperative mortality rate was 2.6%. All patients had early post-operative echocardiography. According to this, mitral regurgitation was absent or tiny in 135 patients, grade II in 10 cases and grade III in 2 cases. It was moderate or important in twelve patients. In the late post-operative period. All the others patients were reoperated upon for mitral dysfunction in a mean time of 37 months. The reason for reoperation was in the majority of the cases the recurrence of mitral regurgitation related to increase of valvular and sub valvular disease. The late mortality rate is 7%. Out of 126 reviewed survivors on the long run, 71 patients are asymptomatic in class I, 53 patients in class II and 2 patients in class III NYHA. The estimated mitral regurgitation by echography in those patients is absent or trivial in 96 cases. grade II in 29 cases and grade III in one case. Mitral valvuloplasty is the preferred procedure in mitral insufficiency surgical management. It is associated to a low early mortality and morbidity rate. Despite the need for reoperation in about 10% of the cases in the long follow-up, mitral repair offers a good quality of life without anticoagulant treatment.     

Practical value of echo Doppler evaluation of aortic and mitral stenosis: a comparative study with cardiac catheterization

This retrospective analysis compares data derived by echocardiography and cardiac catheterization in the evaluation of aortic and mitral valve stenosis. Sixty-seven patients, aged 69 +/- 12 years, underwent 76 catheterization procedures. In all studies the Doppler recording was technically adequate. In 64 studies of patients with aortic stenosis, correlation was good between the gradient obtained at catheterization (peak 51 +/- 28 mm Hg, mean 48 +/- 24 mm Hg) and the Doppler gradient (peak 73 +/- 29 mm Hg, mean 41 +/- 17 mm Hg) (R = 0.78 peak, 0.77 mean). In 15 studies the aortic valve area, 0.8 +/- 0.2 cm2, calculated by the simplified continuity equation, correlated well with the catheterization valve area, 0.7 +/- 0.3 cm2, calculated by the Gorlin equation (R = 0.80). In 14 studies in mitral stenosis patients, the mean gradient at catheterization was 11 +/- 5 mm Hg compared to the Doppler gradient of 8 +/- 4 mm Hg (R = 0.58). The mitral valve area was 1.1 +/- 0.3 cm2 by the Gorlin equation and 1.2 +/- 0.3 cm2 by echo Doppler, using pressure half-time. When cardiac rhythm, the presence and severity of regurgitation, and the cardiac index were analyzed, none was shown to have demonstrable influence on the accuracy of the Doppler study. Doppler echocardiography can be used reliably to assess valvular stenosis in a clinical, noninvasive laboratory where routine tests are performed and interpreted by more than one individual.     

自体心包材料二尖瓣环成形术的中期结果

目的 回顾性分析自体心包材料二尖瓣环成形术的中期效果.方法 采用自体心包材料行二尖瓣环成形术48例.Carpentier分型：Ⅰ型5例,Ⅱ型41例,Ⅲ型2例.瓣叶及瓣下结构成形包括后叶四边形切除30例,瓣叶修补7例,腱索转移4例,“缘对缘”技术2例,人工腱索3例.伴随手术包括主动脉瓣替换1例,三尖瓣成形11例,冠状动脉旁路移植术9例,冠状动脉肌桥松解1例,永久性起搏器植入1例.自体心包条的长度为（51.9 ±2.8）cm.术后随访15～96（62.2 ±21.3）个月.采用门诊随访及电话随访方式,随访内容包括临床症状、心功能、超声心动图检查等.结果 术后左心室舒张末期内径[（45.1±1.3） mm vs（58.6±1.7）mm,t=12.85,P＜0.01]、左心房内径[（38.0±1.4）mm vs （50.6±1.6） mm,t=9.58,P＜0.01]明显缩小.全组早期术后无明显反流.术后30 d内死亡1例.远期无死亡,术后发生脑梗死1例,远期出现中度反流1例.无溶血并发症,无再次手术.结论 自体心包材料二尖瓣环成形是一种抗凝并发症发生率低、耐久性可、心功能维护好、廉价的成形方法.     

Echocardiographic factors determining immediate result of percutaneous mitral balloon commissurotomy

AIM: Define echocardiographic predictors of the result after percutaneous mitral balloon commissurotomy (PMC). METHODS: PMC by the Inoue balloon was attempted in 247 patients (77% female) with severe mitral valve stenosis. The mean age was 35 years. All the patients had undergone echocardiographic examination before PMC to assess mitral anatomy, commissural calcification, and to determine the Wilkins score. RESULTS: The mean value of Wilkins score was 7,98 +/- 1,61 (range 5-13) and the mean mitral valve area (MVA) before PMC was 1 +/- 0,19 cm2 (range 0,5- 1,4 cm2). 29 patients (11,7%) had one-commissural calcification and 2 patients (0,8%) had bi-commissural calcifications. After PMC, the mean MVA increased to 1,79 +/- 0,34 cm2 (p <0,001) resulting in a success rate of 83%. Severe mitral regurgitation (> or =grade 3) occurred in five patients (2%). Wilkins score was an independent predictor of the immediate result of PMC but, if > 8, this score had a weak predictive value. Commissural morphology was another independent predictor of the immediate result of PMC. CONCLUSION: Echocardiography is now the cornerstone for the assessment of mitral anatomy before PMC and should integrate Wilkins score and commissural morphology for the selection of patients to PMC.     

Predictive factors of mortality in combined coronary and vascular surgery. Report of 46 cases

From 1994 and 2003, 46 patients underwent surgical myocardial revascularisation associated to valvular surgery. Surgical indications were for valvular disease in 13 cases (28%), for coronary disease in 16 cases (35%) and associated coronary and valvular disease in 17 cases (37%); Isolated conservative mitral repair was performed in 22 cases (48%); mitral valve replacement in 10 cases (41%), aortic valve replacement in 11 cases (46%) associated mitral and aortic surgery in 3 cases (13%). Intra-aortic balloon pump was used in 4 patients (9%). In the post operative period complete atrio-ventricular heart bloc occurred in 2 cases. For the entire group, 8 deaths (17%) occurred in the hospital, related to low cardiac output in 5 cases (63%). Long term follow up was achieved in a mean period of 18 months. 25 patients (68%) were asymptomatic and one late death occurred after severe heart failure. The predictive factors of hospital mortality were: preoperative ischemic mitral insufficiency. Various large series in the literature have documented operative risk of myocardial revascularisation when combined with valve surgery. In our group the high rate of hospital mortality (17%) explains the difficulties in medical and surgical care of this combined valvular and coronary disease especially in the perioperative period.     

感染性心内膜炎外科治疗--附21例报告

目的　回顾分析感染性心内膜炎外科治疗经验。方法　对2 1例感染性心内膜炎患者术中彻底清除炎症坏死组织后,作主动脉瓣置换(AVR) 10例、二尖瓣置换(MVR) 7例、MVR 三尖瓣DeVega成形1例、三尖瓣置换(TVR) 1例、三尖瓣瓣膜缺损修复2例;同期室间隔缺损(VSD)修补2例、漏斗胸矫治1例;本组急症手术7例,均为主动脉瓣病变,其中高热不退2例、循环衰竭少尿5例;围手术期均使用足量敏感或广谱抗生素、改善心功能和全身营养支持治疗。结果　全组术后早期死亡2例,1例死于多器官系统衰竭(MOSF)、1例死于脑血管意外,其余19例均痊愈出院。结论　手术可提高感染性心内膜炎治疗成功率。恰当的手术时机、合理的手术方法和正确的围手术期处理,均是外科治疗成功的关键。     

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.

OBJECTIVE: The prevalence of cardiac valvular regurgitation demonstrated by echocardiography in patients who took appetite-suppressant medication for weight loss has been assessed at 5%-30%. We studied 86 patients who had echocardiograms before treatment with appetite suppressants to determine the incidence of new cases and to evaluate the clinical implication of the echocardiographic findings. RESEARCH METHODS AND PROCEDURES: We studied 69 men [Mean+/-Standard Deviation (S) age 49+/-8] and 17 women (mean+/-S age 50+/-7) who had 233 echocardiograms before, during, and after a weight-loss program that used predominantly fenfluramine (or dexfenfluramine) with mazindol (or phentermine). Mean drug exposure was 17 months. Blinded echocardiographic readings were performed to identify and grade aortic regurgitation (AR) or mitral regurgitation (MR). RESULTS: Seven of 86 patients (8%) had pre-existing regurgitation with five (6%) meeting our case definition. Thirteen (16.5%) of initially normal patients developed valvular regurgitation and were new cases. Of the new cases, 12 were grade I/IV AR and one was both grade II/III MR and II/IV AR. All 13 patients were asymptomatic, and only two aortic insufficiency murmurs could be auscultated. There was significantly greater risk for developing valvulopathy for those who took medications longer than 6 months (p = 0.03), and no new cases were observed in patients exposed for less than 8 months. No increased risk associated with age, presence of hypertension, or exposure to fenfluramine-phentermine combination was demonstrated. Although there was a higher incidence of new regurgitation in women (31% vs. 13% for men), this was not statistically significant (p = 0.093). DISCUSSION: Some patients who had normal echocardiograms at baseline developed cardiac valvular regurgitation after exposure to fenfluramine or dexfenfluramine with mazindol or phentermine. The development of valvulopathy was significantly correlated with duration of exposure. The clinical implications of echocardiographically demonstrated regurgitation are uncertain, since there were only two audible murmurs and no other clinically relevant signs or symptoms among the patients.     

275例主动脉瓣置换术应用连续缝合法的临床观察

目的探讨主动脉瓣置换中连续缝合方法的应用。方法275例病人主动脉瓣置换采用2/0Prolene线连续缝合法,用3根线265例、1根线10例。同期行二尖瓣置换232例,三尖瓣置换5例,三尖瓣成形112例,升主动脉置换9例,左房血栓清除术32例。结果全组均置入人工机械瓣膜,1例体外循环中发生抑肽酶过敏,需用阿拉明和大剂量激素;1例发生鱼精蛋白过敏再次转流,其他病例手术顺利。无1例住院死亡和严重并发症发生。结论采用连续缝合方法可简化手术操作,减少心肌缺血和转流时间,有利于心肌保护并减少术后并发症。     

Absence of cardiac valve dysfunction in obese patients treated with sibutramine.

OBJECTIVE: Serotonin-releasing agents prescribed as weight-loss medications have been implicated as a cause of acquired aortic and mitral valve abnormalities. Sibutramine hydrochloride (MERIDIA) is a serotonin and norepinephrine reuptake inhibitor with proven efficacy of weight reduction. The purpose of this study was to determine the incidence of cardiac valve disease in sibutraminetreated patients. RESEARCH METHODS AND PROCEDURES: Obese patients with type 2 diabetes mellitus enrolled in an ongoing double-blind, placebo-controlled, parallel-arm, 12-month study of sibutramine (followed by a 12-month open label extension) underwent transthoracic echocardiographic imaging and color Doppler interrogation for assessment of cardiac valve anatomy and function. RESULTS: A total of 210 patients were evaluated. Of these, 133 were receiving sibutramine (72 in the double-blind period), and 77 were receiving placebo. The mean+/-Standard Deviation age was 54+/-9 years, and the mean duration of treatment was 229+/-117 days (approximately 7.6 months). The prevalence of left-sided cardiac valve dysfunction was low and similar for the two treatment groups (sibutramine 3/133, or 2.3%; placebo 2/77, or 2.6%). All five cases were cases of aortic insufficiency; four were mild, one was severe (in a placebo patient). All three sibutramine cases were patients over age 50; two had a history of systemic hypertension. CONCLUSION: The prevalence of left-sided cardiac valve dysfunction was not higher than background in obese patients treated with sibutramine for an average of 7.6 months.     

Surgical management with mitral valve replacement in young infants with congenital mitral valve diseases and complete atrioventricular septal defect

Objectives: The mechanical valve replacement may be the only option if the failing mitral valve cannot be repaired in complete AV septal defect (CAVSD), or congenital mitral valve stenosis and regurgitation in infants. In young infants the small mitral annulus - prothesis mismatch is a big problem. Aim: To assess the possibility of the left AV orifice repair and the necessity of mechanical valve replacement in CAVSD in young infants. Methods: Single center, retrospective study of 82 infants (13 pts under 3 months) who underwent complete repair of CAVSD between 2001 and 2007. Mechanical (bileaflet) valve replacement was required in 7 pts (5 weeks-7 months, 3.5-5 kg). The time interval between the two operations was 0-7 days, but the smallest baby spent 38 days in the intensive care unit waiting for increasing of his mitral annulus size from 11 to 15 mm. (Types of implanted valves: 2 Carbomedics 16 mm, 3 ATS 16 mm, 1 Sorin 17 mm, 1 Sorin 19 mm.) ATS 16 mm valves were implanted in 2 infants each with congenital mitral valve stenosis and regurgutation. Results: Early mortality (30 days) was 0, but 2 pts died in sepsis on the 46th and 71st postoperative day, respectively. In the follow-up period of 1-6 (mean 3) years 1 child (18 months later) needed reoperation (pannus removal), now all pts are doing well. Anticoagulation therapy was difficult in some cases without complication. Conclusions: The surgical repair of congenital mitral valve diseases and CAVSD can be performed successfully in very young infants. If the anatomic characteristics of the mitral valve is not suitable for repair, only mechanical mitral valve replacement can be performed successfully even in sometimes hopeless situation (one of our pts of 3.5 kg weight, is the smallest baby mentioned in the literature). Our early and mid-time results are good, but the re-replacement will be an unavoidable problem in the future.     

Percutaneous mitral commissurotomy. 5-year results

Long-term results of percutaneous mitral commissurotomy were evaluated in 410 patients with mean age of 31 years (18 to 68 years). 48% of patients had mean thickened leaflets, 35% had calcified valves and 17% had flexible leaflets and subvalvular apparatus. Procedure was performed with a double balloon in 57% and with Inoue's balloon in 43% patients. A good immediate results was obtained in 77% of patients. A good result was defined as a mitral valve area > or = 1.5 cm2 without mitral regurgitation. Clinical follow-up concern 378 patients. The actuarial 5 years rate were 84% in our serie, without surgery or new percutaneous mitral commissurotomy and good functional results (NYHA class I or II) were 71%. Valvular anatomy, immediate results (mitral valve area), history of mitral commissurotomy, old patients, atrial fibrillation can influence strongly the results.     

心内结构无异常胎儿的心脏瓣膜返流超声检查分析

【摘要】目的观察心内结构尤异常的胎儿瓣膜返流出现情况,分析不同孕间符个瓣膜返流愉出率的不同和原闵。方法总结296例往我院做胎儿超声筛查的胎心,除先天性心内结构畸形、动脉导管收缩或早闭病例外,分析不同时期各个瓣膜返流的检出率、结果20～24孕周胎儿,三尖瓣返流检出率10％,1例为巾度,余均为轻度;肺动脉瓣返流检出率3．4％．均为轻度;无二尖瓣和主动脉瓣返流胎心。25～29孕周胎儿,三尖瓣返流检出率53．36％,中度返流18例;二尖瓣返流检出率7．92％,均为轻度返流;肺动脉瓣返流检出率7．03％,均为辑度;主动脉瓣返流枪出率0．014％,均为轻度：30～34孕周胎儿,：三尖瓣返流检出率59％．中度返流4例：二尖瓣轻度返流检出率13％,肺动脉瓣轻度返流检出率14％．无主动脉瓣返流榆出。35～38孕周胎儿,三尖瓣轻度返流检出率58．79％,均为轻度返流;二尖瓣返流检出牢0．17％;肺动脉瓣返流检出牢0．07％;无主动脉瓣返流柃出。结论心内结构无异常的胎儿,出现瓣膜返流的情况很普遍,以—尖瓣返流检出率最高,瓣膜返流与孕阍大小有密切相父性.     

Large ostium secundum atrial septal defect discovered after severe mitral regurgitation. A case report

Mitral regurgitation is associated with ostium secundum atrial septal defect in about 22% of cases. mitral valve prolapse induced by atrial shunt is the main cause of this regurgitation. Ususually, atrial septal defect discovery precedes that of mitral regurgitation. The aim of this paper is to focus on clinical, hemodynamic and evolutive details of atrial septal defect and mitral regurgitation association. We report the case of large atrial septal defect in 37 years old girl referred for hemodynamic investigation of mitral regurgitation. The divergence of clinical data, electrocardiogram and echocardiography findings has led to atrial septal defect discovery. Hemodynamic data showed severe pulmonary arterial hypertension (medium pulmonary arterial pressure: 45 mmhg). Hence, mitral valve substitution by mechanical prosthesis and closure of atrial septal defect have been carried out. Ten hours after surgery, death occurred because of severe pulmonary arterial hypertension and heart failure. CONCLUSION: Association of severe mitral regurgitation and large ostium secundum atrial septal defect is an original anatomo-clinic entity caracterized by mitral valve lesions diversity and severe secondary pulmonary arterial hypertension. Danger of such a hypertension is due to progressive and infra clinical rise of pulmonary resistances and association of increased pulmonary blood flow and capillary pulmonary hypertension.     

Surgery of the mitral valve--in the work of József Kudász

The author described his results of surgical treatment of mitral valve disease. Of 57 patients, the isolated mitral procedure was performed in 72%, and the combined (valve and coronary) in 28% of the cases. In 75% of the patients valve repair, and in 25% valve replacement were performed. There were 2 cases (3.5%) of early mortality after combined surgery where patients had also ischaemic heart disease. All the replaced valve prostheses and 84% of repaired mitral valve had a normal function. The mitral regurgitation was moderate in 14%, of cases and mild in 2% of cases at the follow up, but no reoperation was needed. After the surgery 85% of patients had sinus rhythm, 13% had atrial arrhythmia and in 2% the pacemaker was needed. Attempt of valve repair had to be made in all patients with mitral valve disease which can be performed in almost every case of degenerative valve prolapse and the rupture of chordae tendineae.     

超声斑点追踪及成像技术评价主动脉瓣反流患者左室扭转运动

内容:目的:本研究旨在应用二维斑点追踪及成像技术评价主动脉瓣反流(AR)患者左室二维应变及扭转运动,以期探讨其左室功能改变.方法:95例经二维超声心动图诊断为单纯性AR患者,按照反流程度分为轻、中、重度组.30例健康志愿者.行常规二维超声心动图并二维斑点追踪成像检查,采集左室心尖四腔及短轴各节段动态图像,应用EchoPAC工作站软件行脱机分析.比较不同程度AR患者和健康志愿者左室功能改变.结果:①各组间年龄、性别、身高、体重、体表面积和心率的差异均无统计学意义(P>0.05).②轻度AR组与正常对照组比较舒张末期左室内径、收缩末期左室内径、舒张末期左室容积、收缩末期左室容积、左室射血分数、二尖瓣口舒张期E峰、A峰及E/A比值差异均无统计学意义(P>0.05).中度AR组及重度AR组与正常对照组相比,舒张末期左室内径、舒张末期左室容积增大(P<0.05).中度AR组与对照组相比左室射血分数、二尖瓣口舒张期E、A峰及E/A比值的差异均无明显统计学意义(P>0.05).重度AR组左室射血分数与对照组相比有显著差异(P<0.05),但二尖瓣口舒张期E、A峰及E/A比值的差异则无明显统计学意义(P>0.05).③轻度AR组心底、心尖部旋转及扭转曲线与正常对照组差异无明显统计学意义(P>0.05).中度AR组心底、心尖部旋转及扭转角度较正常对照组明显增大(P<0.05).而重度AR组心底、心尖部旋转及扭转角度则较正常对照组明显减小(P<0.05).     

风湿性心脏病合并心脏恶液质综合征的外科治疗

目的　探讨风湿性心脏病合并心脏恶液质综合征的外科治疗方法和特点。方法　对 1996年 4月至 2 0 0 2年12月符合心脏恶液质综合征诊断标准的 18例风湿性心脏病患者外科治疗的临床资料进行回顾性分析 ,其中二尖瓣置换术 14例 ,二尖瓣及主动脉瓣置换术 4例 ,18例均同时进行 De Vega三尖瓣成形术。结果　术后主要并发症为低心排综合征及在此基础上并发的多脏器功能衰竭 ,早期死亡 4例 ,均为多脏器功能衰竭。结论　外科治疗可提高风湿性心脏病合并心脏恶液质综合征病人的治疗成功率和长期存活率 ,正确恰当的围术期处理是手术成功的关键。     

经食管实时三维超声心动图评价房性心律失常对二尖瓣结构和功能的影响

目的:应用经食管实时三维超声心动图(RT-3D-TEE)技术,探讨房性心律失常对二尖瓣结构和功能的影响.方法:选取2018年6月~2019年6月本院收治的房性心律失常拟行射频消融的患者49例纳入观察组,另外选取21例正常窦性心律者作为对照组,所有患者均行经胸超声心电图(TTE)和经食管实时三维超声心动图(RT-3D-TEE)检查,将两组患者的瓣环投影面积(A2D)、瓣环周长(C3D)、瓣环高度(H)、瓣环前后径(DAP)、瓣环前外侧至后内侧直径(DAIPm)、左室射血分数(LVEF)、左心房前后径(Lad)等参数进行比较,并分别计算对合面积和对合指数,之后采取二项Logistic回归分析或逐步线性回归对各参数及临床因素与对合指数的相关性进行分析.结果:两组患者在LVEF和对合面积方面的比较无明显差异(P>0.05),在A2D、C3D、H、DA、PDAIPm、Lad方面的比较,房性心律失常组患者明显高于正常窦性心律组患者(P<0.05),且观察组患者的对合指数明显降低(P<0.05).将49例观察组患者以不同心律失常类型分为持续性房颤、阵发性房颤、房扑、混合型房性心律失常4个亚组,采用单因素方差分析,发现在LVEF、C3D、Lad、对合指数方面的比较,各亚组间无明显差异(P>0.05).采用二项Logistic回归分析发现,女性是导致对合指数低的危险因素,另外对合指数较低、房性心律失常是导致二尖瓣返流的重要因素.结论:房性心律失常对患者二尖瓣的A2D、C3D、H、DA、PDAIPm、Lad等都会造成较大影响,从而降低对合指数,影响二尖瓣的正常功能,导致二尖瓣返流的发生.     

Development and results of valve replacement surgery at the Városmajor Clinic 1976-1990 (retorospective clinical analysis)]

In Hungary valve replacement is still a major indication for heart surgery in adults. In the Cardiovascular Surgical Clinic of Semmelweis Medical University of Budapest from 1976 to 1990 2435 patients were operated for valve disease. Majority of the cases had single (aortic n = 856, mitral n = 912) or double (aortic + mitral n = 513) valve replacement. Over this 15 years period there have been many alterations in patients characteristics and surgical technique as well. In spite of the increasing mean age of patients the operative mortality has decreased (in the last 5 years period it was 2.7%, 5.5% and 7.9% in the three groups respectively). At the same time the number of patients requiring valve re-replacement or combined valve + coronary procedure has increased. The use of bioprosthetic valves has fallen below 10 percent from the 60--80 percent observed between 1976--1980. The analysis showes excellent surgical results in the field of valve replacement in Hungary.